Mayo Clinic's Child and Adolescent Anxiety Disorders program provides advanced, evidence-based medical and psychological treatment for anxiety disorders, including:
The Mayo Clinic Child and Adolescent Anxiety Disorders program includes three primary services:
Child and Adolescent Anxiety Diagnostic Clinic (CADC)
The CADC is a comprehensive, one-day assessment clinic for children and adolescents with heightened anxiety, fears, nervousness and worry. Clinic staff thoroughly evaluate the patient and provide diagnosis and treatment recommendations in a time-efficient manner. A structured diagnostic interview, questionnaires and clinical interviews are used in the evaluation process.
The clinic is staffed by a clinical child and adolescent psychologist and psychiatrist who specialize in anxiety disorders, which allows for an integrated medical and psychological understanding of the child's symptoms.
Child Outpatient Anxiety Treatment
Cognitive behavioral therapy and medication management are available on an outpatient basis. Psychotherapy treatment consists primarily of exposure-based cognitive behavioral therapy. This treatment teaches children skills to manage their anxiety and teaches parents to effectively provide support. With these tools in place, the child and therapist develop a list of situations that cause the child to feel anxious. With the help of the therapist, the child then gradually faces these fears and learns that they can be managed. Treatment typically consists of 10 to 16 sessions completed on a weekly basis.
Intensive Child Anxiety Treatment Service (ICATS)
Treatment for child and adolescent anxiety disorders also is available in an intensive format for families unable to spend extended time at Mayo Clinic. Treatment can be provided in a 10-session format over five days. The goals of these intensive treatments are to:
Follow-up care is provided via phone.
Children and families receiving treatment through the Child and Adolescent Anxiety Disorders program can participate in clinical trials. These trials include the development of diagnostic tools; development and improvement of treatment approaches; understanding the individual and environmental factors that contribute to anxiety disorders; and using neuroimaging to investigate the neurobiology of anxiety disorders.